Skip to content

ALB

Albemarle Corporation

NYSE · USBasic MaterialsChemicals - Specialty
$118.20-2.14%

Price as of Jul 20, 2026

ALB growth

Albemarle Corporation growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+7.9%
EBITDA
+216.4%
EBIT
+165.0%
EPS
+69.4%
Free cash flow
+469.1%
Operating cash flow
-5.0%

Forward estimates

Revenue
+13.5%
EBITDA
+38.1%
EPS
+353.1%

Three-year CAGR

Revenue
-11.1%
EBITDA
-46.4%
EBIT
-66.5%
Net income
+56.7%
EPS
+48.7%
Free cash flow
+2.3%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.